Tobacco use and cancer: An epidemiologic perspective for geneticists

Oncogene

Volumn 21, Issue 48 REV. ISS. 6, 2002, Pages 7307-7325

  Thun, Michael J ^a   Henley, S Jane ^a   Calle, Eugenia E ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

Cancer; Genetic epidemiology; Tobacco

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SUSCEPTIBILITY; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; COLORECTAL CANCER; DNA REPAIR; ENVIRONMENTAL EXPOSURE; HUMAN; KIDNEY CANCER; LIVER CANCER; PANCREAS CANCER; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SMOKING; SOMATIC MUTATION; STOMACH CANCER; TOBACCO; UNITED STATES; UTERINE CERVIX CANCER;

EPIDEMIOLOGY, MOLECULAR; HUMANS; LUNG NEOPLASMS; SMOKING;

NICOTIANA TABACUM;

EID: 0037152649     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205807     Document Type: Article

References (163)

1. Ahsan H, Neugut A and Gammon M. (1997). Cancer Epidemiol. Biomarkers Prev., 10, 779-782.
2. Ambrosone C, Freudenheim J, Graham S, Marshall J, Vena J, Brasure J, Michalek A, Laughlin R, Nemoto T, Gillenwater K and Shield P. (1996). J. Am. Med. Assoc., 276, 1494-1501.
3. Auerbach O and Garfinkel L. (1986). Digest. Dis. Sci., 31, 1014-1020.
4. Auerbach O, Hammond C and Garfinkel L. (1979). N. Engl. J. Med., 300, 381-386.
5. Auerbach O, Hammond E and Garfinkel L. (1970). Cancer, 25, 92-104.
6. Auerbach O, Stout A, Hammond E and Garfinkel L. (1961). N. Engl. J. Med., 265, 253-267.
7. Auerbach O, Stout A, Hammond E and Garfinkel L. (1962). N. Engl. J. Med., 267, 119-125.
8. Auerbach O, Stout A, Hammond E and Garfinkel L. (1964). Am. Rev. Resp. Dis., 90, 867-876.
9. Auerbach O, Stout A, Hammond E and Garfinkel L. (1965). Arch. Environ. Health, 11, 4-15.
10. Baron J. (1996). Br. Med. Bull., 52, 58-73.
11. Bartsch H, Nair U, Risch A, Rojas M, Wikman H and Alexandrov K. (2000). Cancer Epidemiol. Biomarkers Prev., 9, 3-28.
12. Bennett W, Alavanja M, Blomeke B, Vahakangas K, Castren K, Welsh J, Bowman ED, Khan MA, Flieder DB and Harris CC. (1999). J. Natl. Cancer Inst., 91, 2009-2014.
13. Benowitz N. (2001). Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine. Smoking and Tobacco Control Monograph No. 13. NIH Pub. No. 02-5074. U.S. Department of Health and Human Services, National Cancer Institute: Bethesda, MD.
14. Benowitz N, Perez-Stable E, Herrera B and Jacob P. (2002). J. Natl. Cancer Inst., 94, 108-114.
15. Bergen A and Caporaso N. (1999). J. Natl. Cancer Inst., 91, 1365-1375.
16. Berkson J. (1955). Proceedings of the Staff Meetings of the Mayo Clinic, 30, 319-348.
17. Berkson J. (1958). J. Am. Star. Assoc., 53, 28-38.
18. Best E, Josie G and Walker C. (1961). Canad. J. Public Health, 52, 99-106.
19. Brockton N, Little J, Sharp L and Cotton S. (2000). Am. J. Epidemiol., 151, 846-861.
20. Brownson R, Chang J and Davis J. (1992). Epidemiology, 3, 61-64.
21. Burns D, Lee L, Shen L, Gilpin E, Tolley H, Vaughn J and Shanks T. (eds) (1997). Cigarette Smoking Behavior in the United States. National Institutes of Health: Bethesda, MD.
22. Califano J, Leong P, Koch W, Eisenberger C, Sidransky D and Westra W. (1999). Clin. Cancer Res., 5, 1862-1867.
23. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W and Sidransky D. (1996). Cancer Res., 56, 2488-2492.
24. Califano J, Westra W, Meininger G, Corio R, Koch W and Sidransky D. (2000). Clin. Cancer Res., 6, 347-352.
25. Cardon L and Bell J. (2001), Nature Reviews/Genetics, 2, 91-99.
26. Castelao J, Yuan J, Skipper P, Tannenbaum S, Gago-Dominguez M, Crowder J, Ross R and Yu M. (2001). J. Natl. Cancer Inst., 93, 538-545.
27. CDC. (1997). MMWR, 46, 1217-1220.
28. CDC. (2002). MMWR, 51, 300-303.
29. Clemmesen J. (1965). Statistical Studies in the Aetiology of Malignant Neoplasms. I. Review and Results. Copenhagen: Munksgaard.
30. Cohn B, Wingard D, Cirillo P, Cohen R and Kaplan G. (1996). J. Natl. Cancer Inst., 88, 1867.
31. Cooper E, Lamb F, Sanders E and Hirst E. (1932). J. Hygiene, London, 32, 293-300.
32. Corrao M, Guindon G, Cokkinides V and Sharma N. (2000a). Bulletin of the World Health Organization, 78, 884-890.
33. Corrao M, Guindon G, Sharma N and Shokoohi D. (2000b). Tobacco Control: Country Profiles. American Cancer Society: Atlanta, GA.
34. Cosma G, Crofts F, Currie D, Wirgin I, Toniolo P and Garte S. (1993). Cancer Epidemiol. Biomarkers Prev., 2, 53-57.
35. Crofts F, Cosma G, Currie D, Taioli E, Toniolo P and Garte S. (1993). Carcinogenesis, 14, 1729-1731.
36. Croninger A, Graham E and Wynder E. (1958). Cancer Res., 18, 1263-1271.
37. Denissenko M, Pao A, Tang M-S and Pfeifer G. (1996). Science, 274, 430-432.
38. Djordjevic M, Stellman S and Zang E. (2000). J. Natl. Cancer Inst., 92, 106-111.
39. Doll R. (1996). Br. Med. Bull., 52, 35-49.
40. Doll R. (1998). Stat. Methods Med. Res., 7, 87-117.
41. Doll R and Hill A. (1950). Br. Med. J., 2, 739-748.
42. Doll R and Hill A. (1954). Br. Med. J., 1, 1451-1455.
43. Doll R and Hill A. (1956). Br. Med. J., 2, 1071-1081.
44. Doll R and Hill A. (1964). Br. Med. J., 1, 1399-1410.
45. Doll R, Hill A and Kreyberg L. (1957). Br. J. Cancer, ii, 43-48.
46. Doll R and Peto R. (1978). J. Epidemiol. Community Health, 32, 303-313.
47. Doll R and Peto R. (1981). J. Natl. Cancer Inst., 66, 1191-1308.
48. Dorn H. (1959). Public Health Rep., 74, 581-593.
49. Eberhardt M, Ingram D and Makuc D et al. (2001). Urban and Rural Health Chartbook. Health, United States, 2001. National Center for Health Statistics: Hyattsville, Maryland.
50. Engelbreth-Holm J and Ahlmann J. (1957). Acta Pathalogical Microbiology Scandinavia, 41, 267-272.
51. Ford B. (1994). SmokeScreen - A guide to the personal risks and global effects of the cigarette habit. North Perth, WA, Australia: Halcyon Press.
52. Fraumeni J and Mason T. (1974). J. Natl. Cancer Inst., 52, 659-665.
53. Gaffney M and Altshuler B. (1988). J. Natl. Cancer Inst., 80, 925-931.
54. Gammon M, Schoenberg J, Ahsan H, Risch H, Vaughan T, Chow W, Rotterdam H, West A, Dubrow R, Stanford J, Mayne S, Farrow D, Niwa S, Blot W and Fraumeni Jr J. (1997). J. Natl. Cancer Inst., 89, 1277-1284.
55. Garcia-Closas M and Lubin J. (1999). Am. J. Epidemiol., 149, 689-692.
56. Garte S. (2001). Cancer Epidemiol. Biomarkers Prev., 10, 1233-1237.
57. Geisler S and Olshan A. (2001). Am. J. Epidemiol., 154, 95-105.
58. Giovanucci E. (2001). Cancer Epidemiol. Biomarkers Prev., 10, 725-731.
59. Glantz S, Slade J, Bero L, Hanauer P and Barnes D. (1996). The Cigarette Papers. Glantz S, Slade J, Bero L, Hanauer P, Barnes D. (eds). Berkeley USA: University of California Press, pp 1-24.
60. Green J, Banks E, Berrington A, Darby S, Deo H and Newton R. (2000). Br. J. Cancer, 83, 412-417.
61. Guerin M and Cuzin J. (1957). Bulletin of the Association of France Cancer, 44, 387-408.
62. Guo Z, Yamaguchi K, Sanchez-Cespedes M, Westra W, Koch W and Sidransky D. (2001). Clin. Cancer Res., 7, 1963-1968.
63. Haenszel W, Shimkin M and Miller H. (1956). Public Health Monograph Number 45. PHS Pub. No. 463. Public Health Service. U.S. Government Printing Office, 1956: Washington, D.C.
64. Hammond E. (1966). Natl. Cancer Inst. Monogr., 19, 127-204.
65. Hammond E and Horn D. (1958). JAMA, 166, 1294-1308.
66. Harris J. (1983). J. Natl. Cancer Inst., 71, 473-479.
67. Harris R, Zang E, Anderson J and Wynder E. (1993). Int. J. Epidemiol., 22, 592-599.
68. Heath A, Cares R, Martin N, Meyer J, Hewitt J and Neale M et al. (1995). Behavior Genetic Approaches in Behavioral Medicine. Turner J, Cardon L, Hewitt J. (eds). New York: Plenum Press, pp 45-66.
69. Hecht S. (1999). J. Natl. Cancer Inst., 91, 1194-1210.
70. Hecht S. (2000). J. Natl. Cancer Inst., 92, 782-783.
71. Henningfield J, Cohen C and Pickworth W. (1993). Nicotine Addiction, Principles and Management. Orleans C, Slade J. (eds). New York: Oxford University Press, pp 24-45.
72. Hickey K, Do K-A and Green A. (2001). Epidemiologic Reviews, 23, 115-125.
73. Hill A. (1965). Proc. Royal Soc. Med., 58, 295-300.
74. Hopper J, Southey M, Dite G, Jolley D, Giles G, McCredie M, Easton D, Venter D and and Australian Breast Cancer Family Study. (1999). Cancer Epidemiol. Biomarkers Prev., 8, 741-747.
75. Houlston R. (1999). Cancer Epidemiol. Biomarkers Prev., 8, 675-682.
76. IARC. (1986). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Smoking. International Agency for Reseach on Cancer: Lyon.
77. IARC. (1987). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42. International Agency for Reseach on Cancer: Lyon.
78. Kahn H. (1966). Monograph 19, Epidemiological Study of Cancer and Other Chronic Diseases. Haenszel W. (ed.). U.S. Department of Health, Education, and Welfare, Public Health Service, National Cancer Institute: Bethesda, MD, pp 1-126.
79. King T and Brunetta P. (1999). N. Engl. J. Med., 341, 1231-1233.
80. Kreyberg L. (1962). Acta Pathol. Microbiol. Immunol. Scand. Suppl., 157, 11-92.
81. Lagergren J, Bergstrom R, Lindgren A and Nyren O. (2000). Int. J. Cancer, 85, 340-346.
82. Lam T, Ho S, Hedley A, Mak K and Peto R. (2001). BMJ, 323, 361-362.
83. Landi M, Sinha R, Lanh N and Kadlubar F. (1999). Metabolic Polymorphisms and Susceptibility to Cancer Vol. 148 Vineas P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P (eds). Lyon, France: IARC, pp 173-195.
84. Lang M and Pelkonen O. (1999). Metabolic Polymorphisms and Susceptilibity to Cancer, Vol. 148 Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P. (eds). Lyon, France: IARC Scientific Publications, International Agency for Research on Cancer, pp 13-22.
85. Law C, Day N and Chanmugaratnam K. (1976). Int. J. Cancer, 17, 304-309.
86. Lee J, Hong W, Hittelman W, Mao L, Lotan R, Shin D, Benner S, Xu X-C, Lee J, Papadimitrakopoulou V, Geyer C, Perez C, Martin J, El-Naggar A and Lippman S. (2000). Clin. Cancer Res., 6, 1702-1710.
87. Leitch A. (1928). Fifth Annual Report of the British Empire Cancer Campaign. London: British Empire Cancer Campaign, pp 26.
88. Levin M, Goldstein H and Gerhardt P. (1950). J. Am. Med. Assoc., 143, 336-338.
89. Liu BQ, Peto R, Chen ZM, Boreham J, Wu YP, Li JY, Campbell TC and Chen JS. (1998). BMJ, 317, 1411-1422.
90. London S, Idle J, Daly A and Coetzee G. (1999). Lancet, 353, 898-899.
91. Lubin J and Blot W. (1984). J. Natl. Cancer Inst., 73, 383-389.
92. Mabry M, Nelkin B and Baylin S. (1998). The Genetic Basis of Human Cancer. Vogelstein B, Kinzler K. (eds). New York: McGraw-Hill, pp 671-679.
93. Malone K, Daling J, Thompson J, O'Brien C, Francisco L and Ostrander E. (1998). JAMA, 279, 922-929.
94. Mao L, Lee J, Fan Y, Ro J, Batsakis J, Lippman S, Hittelman W and Hong W. (1996). Nat. Med., 2, 682-685.
95. Martin G, Brown J, Eifler C and Houston G. (1999). J. Am. Dent. Assoc., 130, 945-954.
96. Mattson M, Pollack E and Cullen J. (1987). Am. J. Public Health, 77, 425-431.
97. McDuffie H, Klassen D and Dossman J. (1991). J. Clin. Epidemiol., 44, 537-544.
98. McGinnis J and Foege W. (1993). JAMA, 270, 2207-2212.
99. Mills C and Porter M. (1950). Cancer Res., 10, 539-542.
100. Minna J, Roth J and Gazdar A. (2002). Cancer Cell, 1, 49-52.
101. Montesano R, Hainaut P and Hall J. (1997). Application of Biomarkers in Cancer Epidemiology, Vol. 142., Toniolo P, Boffetta P, Shuker D, Rothman N, Hulka B, Pearce N. (eds). Lyon, France: IARC, pp 291-301.
102. Moolgavkar S and Luebeck G. (1990). Risk Analysis, 10, 323-341.
103. Murray C and Lopez A. (1997). Lancet, 349, 1498-1504.
104. Newman B, Mu H, Butler L, Millikan R, Moorman P and King M. (1998). JAMA, 279, 915-921.
105. Niu S-R, Yang G-H, Chen Z-M, Wang J-L, Wang G-H and He X-Z et aL (1998). BMJ, 317, 1423-1424.
106. Novotny T, Warner K, Kendrick J and Remington P. (1988). Am. J. Public Health, 78, 1187-1189.
107. Osann K, Anton-Culver H, Kurosaki T and Taylor T. (1993). Int. J. Cancer, 54, 44-48.
108. Passey R. (1929). Sixth report of British Empire Cancer Research Campaign. British Empire Cancer Campaign: London, p85.
109. Perera F. (1996). J. Natl. Cancer Inst., 88, 496-509.
110. Perez-Stable E, Herrera B, Jacob III P and Benowitz N. (1998). JAMA, 280, 152-156.
111. Perneger T. (2001). J. Natl. Cancer Inst., 93, 1600-1602.
112. Peto R, Darby S, Deo H, Silcocks P, Whitley E and Doll R. (2000). Br. Med. J., 321, 323-329.
113. Peto R, Lopez A, Boreham J, Thun M and Heath Jr C. (1992). Lancet, 339, 1268-1278.
114. Peto R, Lopez A, Boreham J, Thun M and Heath CJ. (1994). Mortality from Smoking in Developed Countries 1950-2000. New York: Oxford University Press.
115. Peto R, Parish S and Gray R. (1985). Age-related Factors in Carcinogenesis, Vol. 58., Likhachex A, Anisimov V, Montesano R. (eds). Lyon, France: IARC, pp 43-53.
116. Pike M and Doll R. (1965). Lancet, 1, 665-668.
117. Prescott E, Osler M, Hein H, Borch-Johnsen K, Lange P, Schnohr P and Vestbo J. (1998). Epidemiology, 79, 79-83.
118. Ratnasinghe D, Yao S, Tangrea J, Qiao Y, Andersen M, Barrett M, Giffen C, Erozan Y, Tockman M and Taylor P. (2001). Cancer Epidemiol. Biomarkers Prev., 10, 119-123.
119. Richie JJ, Carmella S, Muscat J and Scott D. (1997). Cancer Epidemiol. Biomarkers Prev., 6, 783-790.
120. Ries L, Eisner M, Kosary C, Hankey B, Miller B, Clegg L and Edwards B. (2001). SEER Cancer Statistics Review, 1973-1998. Bethesda, MD: National Cancer Institute.
121. Risch H, Howe G, Jain M, Burch J, Holowaty E and Miller A. (1993). Am. J. Epidemiol., 138, 281-293.
122. Roffo A. (1931). Zeitschrift fur Krebsforschung, 33, 321-322.
123. Rothman K and Greenland S. (1998). Modern Epidemiology.. Philadelphia: Lippincott-Raven, pp 7-28.
124. Ryberg D, Hewer A, Phillips D and Haugen A. (1994). Cancer Res., 54, 5801-5803.
125. Schrek R, Baker L, Ballard G and Dolgoff S. (1950). Cancer Res., 10, 49-58.
126. Shields P, Caporaso N, Falk R, Sugimura H, Trivers G, Trump B, Hoover R, Weston A and Harris C. (1993). Cancer Epidemiol. Biomarkers Prev., 2, 481-485.
127. Shriver S, Bourdeau H, Gubish C, Tirpak D, Gaither Davis A, Luketich J and Siegfried J. (2000). J. Natl. Cancer Inst., 92, 24-33.
128. Sidransky D. (1995). Monogr. Natl. Cancer Inst., 17, 27-29.
129. Silverman S. (1998). Oral Cancer., Hamilton: B.C. Decker Inc, pp 25-40.
130. Slade J. (1993). Nicotine Addiction, Principles and Management. Orleans C, Slade J. (eds). New York: Oxford University Press, pp 3-23.
131. Smith S and Fiore M. (1999). Primary Care, 26, 433-461.
132. Sommering S. (1795). De Morbis Vasorum Absorbentium Corporis Humani. Frankfurt: Varrentrapp & Wenner.
133. Spivack S, Fasco M, Walker V and Kaminsky L, (1997). Criti. Rev. Toxicol., 27, 319-365.
134. Stellman S, Takezaki T, Wang L, Chen Y, Citron M, Djordjevic M, Harlap S, Muscat J, Neugut A, Wynder E, Oqawa H, Tajima K and Aoki K. (2001). Cancer Epidemiol. Biomarkers Prev., 10, 1193-1199.
135. Stern M, Umbach D, van Gils C, Lunn R and Taylor J. (2001). Cancer Epidemiol. Biomarkers Prev., 10, 125-131.
136. Stewart J. (2001). Cancer, 91, 2476-2482.
137. Strange R and Fryer A. (1999). Metabolic Polymorphisms and Suseptitibity to Cancer. Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P. (eds). Lyon, France: IARC Scientific Publications No. 148. International Agency for Research on Cancer, pp 231-249.
138. Straub R, Sullivan P, Ma Y, Myakishev M, Harris-Kerr C, Wormley B, Kadambi B, Sadek H, Silverman MA, Webb BT, Neale MC, Bulik CM, Joyce PR and Kandler KS. (1999). Mol. Psychiatry, 4, 129-144.
139. Strong L and Amos C. (1996). Cancer Epidemiology and Prevention. Schottenfeld D, Fraumeni J. (eds). New York: Oxford University Press, pp 559-583.
140. Struewing J, Hartge P, Wacholder S, Baker S, Berlin M, McAdams M, Timmerman M, Brody L and Tucker M. (1997). N. Engl. J. Med., 336, 1401-1408.
141. Sugiura K. (1956). Gann., 47, 243-244.
142. Taioli E, Ford J, Trachman J and Li Y. (1998). Carcinogenesis, 19, 813-817.
143. Thun M. (1998). Tobacco Control, 7, 223-226.
144. Thun M, Calle E, Rodriguez C and Wingo P. (2000). Cancer Epidemiol. Biomarkers Prev., 9, 861-868.
145. Thun M, Day-Lally C, Meyers D, Calle E, Flanders W, Namboodiri M and Heath C. (1997a). Monograph 8 In Changes in Cigarette-related Disease Risks and Their Implication for Prevention and Control. Burns D, Garfinkel L, Samet J. (eds). Bethesda, MD: National Institutes of Health.
146. Thun M, Day-Lally C, Myers D, Calle E, Flanders W, Zhu B, Namboodiri M and Heath CJ. (1997b). National Cancer Institute, Smoking and Tobacco Control, Monograph 8: Changes in Cigarette-Related Disease Risks and Their Implication for Prevention and Control. NIH Publication No. 97-4213. Washington, DC: National Institutes of Health, pp. 305-382.
147. Thun M, Lally C, Flannery J, Calle E, Flanders W and Heath C. (1997c). J. Natl. Cancer Inst., 89, 1580-1586.
148. Tredaniel J, Boffetta P, Buiatti E, Saracci R and Hirsch A. (1997). Int. J. Cancer, 72, 565-573.
149. US Department of Agriculture. (2001). US Department of Agriculture, Commodity Economics Division Research Service: Washington, D.C.
150. US Department of Health and Human Services. (1988). Reducing the Health Consequences of Smoking: 25 Years of Progress A Report of the Surgeon General. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Rockville, MD.
151. US Department of Health and Human Services. (1989). The Health Benefits of Smoking Cessation: A Report of the Surgeon General. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Rockville, MD.
152. US Department of Health and Human Services. (1990). Nicotine Addiction. A Report of the Surgeon General. DHHS Publication No. (CDC) 88-8406: Rockville, MD.
153. US Public Health Service. (1964). Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service. US Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control: Washington, DC.
154. Wakai K, Seki N, Tamakoshi A, Kondo T, Nishino Y, Ito Y, Suzuki K, Ozasa K, Watanabe Y and Ohno Y and et al. (2001). Jpn. J. Cancer Res., 92, 821-828.
155. Weinberg C and Sandler D. (1999). J. Natl. Cancer Inst., 91, 1985-1986.
156. Westra W and Sidransky D. (1998). J. Natl. Cancer Inst., 90, 1500-1501.
157. Wu-Williams A and Samet J. (1994). Epidemiology of Lung Cancer. Samet J (ed.). New York: Marcel Dekker, Inc, pp 71-108.
158. Wynder E and Graham E. (1950). J. Am. Med. Assoc., 143, 329-336.
159. Wynder E, Graham E and Croninger A. (1953). Cancer Res., 13, 855-864.
160. Wynder E, Graham E and Croninger A. (1955). Cancer Res., 15, 445-448.
161. Yuan J-M, Ross R, Wang X-L, Gao Y-T, Henderson B and Yu M. (1996). JAMA, 275, 1646-1650.
162. Zang E and Wynder E. (1992). Cancer, 70, 69-76.
163. Zang E and Wynder E. (1996). J. Natl. Cancer Inst., 88, 183-192.